Code,Cause,ISO3,Year,Sex,Age Group,Population,Deaths,Death rate per 100 000 population,DALY,DALY rate per 100 000 population
1610,Self-harm,CHE,2010,BTSX,YEARS35-39,565132,60.99,10.79,3349.39,592.67
870,Drug use disorders,CHE,2010,BTSX,YEARS35-39,565132,32.72,5.79,3386.02,599.16
1530,Road injury,CHE,2010,BTSX,YEARS35-39,565132,29.15,5.16,2232.34,395.01
700,Breast cancer,CHE,2010,BTSX,YEARS35-39,565132,24.82,4.39,1425.79,252.29
1130,Ischaemic heart disease,CHE,2010,BTSX,YEARS35-39,565132,18.34,3.25,998.61,176.7
751,Brain and nervous system cancers,CHE,2010,BTSX,YEARS35-39,565132,11.66,2.06,639.35,113.13
1230,Cirrhosis of the liver,CHE,2010,BTSX,YEARS35-39,565132,10.17,1.8,554.6,98.14
650,Colon and rectum cancers,CHE,2010,BTSX,YEARS35-39,565132,9.5,1.68,524.66,92.84
680,"Trachea, bronchus, lung cancers",CHE,2010,BTSX,YEARS35-39,565132,8.98,1.59,478.99,84.76
760,"Lymphomas, multiple myeloma",CHE,2010,BTSX,YEARS35-39,565132,6.48,1.15,365.28,64.64
1550,Falls,CHE,2010,BTSX,YEARS35-39,565132,4.94,0.87,3813.14,674.73
640,Stomach cancer,CHE,2010,BTSX,YEARS35-39,565132,4.75,0.84,254.35,45.01
860,Alcohol use disorders,CHE,2010,BTSX,YEARS35-39,565132,4.55,0.81,2930.05,518.47
730,Ovary cancer,CHE,2010,BTSX,YEARS35-39,565132,4.32,0.76,235.85,41.73
1620,Interpersonal violence,CHE,2010,BTSX,YEARS35-39,565132,4.11,0.73,448.65,79.39
1400,Congenital anomalies,CHE,2010,BTSX,YEARS35-39,565132,3.78,0.67,559.22,98.95
690,Melanoma and other skin cancers,CHE,2010,BTSX,YEARS35-39,565132,3.67,0.65,237.34,42
670,Pancreas cancer,CHE,2010,BTSX,YEARS35-39,565132,3.47,0.61,184.36,32.62
100,HIV/AIDS,CHE,2010,BTSX,YEARS35-39,565132,3.47,0.61,315.72,55.87
1140,Stroke,CHE,2010,BTSX,YEARS35-39,565132,3.37,0.6,466.55,82.56
1150,"Cardiomyopathy, myocarditis, endocarditis",CHE,2010,BTSX,YEARS35-39,565132,2.52,0.45,139.05,24.6
630,Oesophagus cancer,CHE,2010,BTSX,YEARS35-39,565132,2.37,0.42,126.31,22.35
390,Lower respiratory infections,CHE,2010,BTSX,YEARS35-39,565132,2.25,0.4,123.84,21.91
850,Schizophrenia,CHE,2010,BTSX,YEARS35-39,565132,2.23,0.39,2081.25,368.28
710,Cervix uteri cancer,CHE,2010,BTSX,YEARS35-39,565132,2.16,0.38,129.99,23
1570,Drowning,CHE,2010,BTSX,YEARS35-39,565132,2.06,0.36,113.85,20.15
800,Diabetes mellitus,CHE,2010,BTSX,YEARS35-39,565132,1.84,0.33,934,165.27
745,Kidney cancer,CHE,2010,BTSX,YEARS35-39,565132,1.3,0.23,73.94,13.08
742,Testicular cancer,CHE,2010,BTSX,YEARS35-39,565132,1.3,0.23,91.73,16.23
752,Gallbladder and biliary tract cancer,CHE,2010,BTSX,YEARS35-39,565132,1.3,0.23,68.75,12.17
660,Liver cancer,CHE,2010,BTSX,YEARS35-39,565132,1.2,0.21,64.79,11.46
980,Multiple sclerosis,CHE,2010,BTSX,YEARS35-39,565132,1.12,0.2,286.54,50.7
950,Alzheimer disease and other dementias,CHE,2010,BTSX,YEARS35-39,565132,1.14,0.2,59.97,10.61
1240,Appendicitis,CHE,2010,BTSX,YEARS35-39,565132,1.14,0.2,81.49,14.42
1190,Asthma,CHE,2010,BTSX,YEARS35-39,565132,1.12,0.2,1469.23,259.98
1244,Inflammatory bowel disease,CHE,2010,BTSX,YEARS35-39,565132,1.14,0.2,282.12,49.92
920,Idiopathic intellectual disability,CHE,2010,BTSX,YEARS35-39,565132,1.12,0.2,220.97,39.1
550,Protein-energy malnutrition,CHE,2010,BTSX,YEARS35-39,565132,1.14,0.2,329.86,58.37
620,Mouth and oropharynx cancers,CHE,2010,BTSX,YEARS35-39,565132,1.08,0.19,65.31,11.56
420,Maternal conditions,CHE,2010,BTSX,YEARS35-39,565132,1.06,0.19,128.73,22.78
750,Bladder cancer,CHE,2010,BTSX,YEARS35-39,565132,1.08,0.19,60.93,10.78
770,Leukaemia,CHE,2010,BTSX,YEARS35-39,565132,1.08,0.19,87.14,15.42
755,Mesothelioma,CHE,2010,BTSX,YEARS35-39,565132,1.08,0.19,57.15,10.11
190,Acute hepatitis B,CHE,2010,BTSX,YEARS35-39,565132,1.07,0.19,60.62,10.73
1575,Exposure to mechanical forces,CHE,2010,BTSX,YEARS35-39,565132,0.96,0.17,1228.97,217.47
1580,Natural disasters,CHE,2010,BTSX,YEARS35-39,565132,0.89,0.16,51.61,9.13
1270,Kidney diseases,CHE,2010,BTSX,YEARS35-39,565132,0.39,0.07,262.41,46.43
1180,Chronic obstructive pulmonary disease,CHE,2010,BTSX,YEARS35-39,565132,0.27,0.05,397.91,70.41
295,Echinococcosis,CHE,2010,BTSX,YEARS35-39,565132,0.31,0.05,16.33,2.89
812,Sickle cell disorders and trait,CHE,2010,BTSX,YEARS35-39,565132,0.17,0.03,45.7,8.09
320,Rabies,CHE,2010,BTSX,YEARS35-39,565132,0.04,0.01,1.89,0.33
205,Acute hepatitis E,CHE,2010,BTSX,YEARS35-39,565132,0.04,0.01,2.75,0.49
1630,Collective violence and legal intervention,CHE,2010,BTSX,YEARS35-39,565132,0.06,0.01,4.67,0.83
1560,"Fire, heat and hot substances",CHE,2010,BTSX,YEARS35-39,565132,0,0,287.3,50.84
1246,Gallbladder and biliary diseases,CHE,2010,BTSX,YEARS35-39,565132,0,0,286.59,50.71
1248,Pancreatitis,CHE,2010,BTSX,YEARS35-39,565132,0,0,12.28,2.17
1220,Peptic ulcer disease,CHE,2010,BTSX,YEARS35-39,565132,0,0,12.02,2.13
1470,Oral conditions,CHE,2010,BTSX,YEARS35-39,565132,0,0,1338.29,236.81
1505,Sudden infant death syndrome,CHE,2010,BTSX,YEARS35-39,565132,0,0,0,0
1540,Poisonings,CHE,2010,BTSX,YEARS35-39,565132,0,0,51.67,9.14
1241,Gastritis and duodenitis,CHE,2010,BTSX,YEARS35-39,565132,0,0,73.76,13.05
1242,Paralytic ileus and intestinal obstruction,CHE,2010,BTSX,YEARS35-39,565132,0,0,6.27,1.11
1280,Benign prostatic hyperplasia,CHE,2010,BTSX,YEARS35-39,565132,0,0,0,0
1290,Urolithiasis,CHE,2010,BTSX,YEARS35-39,565132,0,0,51.91,9.19
1310,Infertility,CHE,2010,BTSX,YEARS35-39,565132,0,0,650.02,115.02
1320,Gynecological diseases,CHE,2010,BTSX,YEARS35-39,565132,0,0,5779.37,1022.66
1330,Skin diseases,CHE,2010,BTSX,YEARS35-39,565132,0,0,1014.17,179.46
1350,Rheumatoid arthritis,CHE,2010,BTSX,YEARS35-39,565132,0,0,187.86,33.24
1360,Osteoarthritis,CHE,2010,BTSX,YEARS35-39,565132,0,0,361.25,63.92
1370,Gout,CHE,2010,BTSX,YEARS35-39,565132,0,0,66.37,11.74
1380,Back and neck pain,CHE,2010,BTSX,YEARS35-39,565132,0,0,7871.23,1392.81
990,Migraine,CHE,2010,BTSX,YEARS35-39,565132,0,0,3388.88,599.66
1000,Non-migraine headache,CHE,2010,BTSX,YEARS35-39,565132,0,0,652.45,115.45
1030,Glaucoma,CHE,2010,BTSX,YEARS35-39,565132,0,0,0,0
1040,Cataracts,CHE,2010,BTSX,YEARS35-39,565132,0,0,18.59,3.29
1050,Uncorrected refractive errors,CHE,2010,BTSX,YEARS35-39,565132,0,0,1203.45,212.95
1060,Macular degeneration,CHE,2010,BTSX,YEARS35-39,565132,0,0,0,0
1070,Other vision loss,CHE,2010,BTSX,YEARS35-39,565132,0,0,92.05,16.29
1080,Other hearing loss,CHE,2010,BTSX,YEARS35-39,565132,0,0,693.31,122.68
1110,Rheumatic heart disease,CHE,2010,BTSX,YEARS35-39,565132,0,0,2.93,0.52
1120,Hypertensive heart disease,CHE,2010,BTSX,YEARS35-39,565132,0,0,1.19,0.21
960,Parkinson disease,CHE,2010,BTSX,YEARS35-39,565132,0,0,11.26,1.99
970,Epilepsy,CHE,2010,BTSX,YEARS35-39,565132,0,0,310.35,54.92
880,Anxiety disorders,CHE,2010,BTSX,YEARS35-39,565132,0,0,4229.32,748.38
890,Eating disorders,CHE,2010,BTSX,YEARS35-39,565132,0,0,1015.27,179.65
900,Autism and Asperger syndrome,CHE,2010,BTSX,YEARS35-39,565132,0,0,471.09,83.36
910,Childhood behavioural disorders,CHE,2010,BTSX,YEARS35-39,565132,0,0,65.06,11.51
220,Malaria,CHE,2010,BTSX,YEARS35-39,565132,0,0,0,0
230,African trypanosomiasis,CHE,2010,BTSX,YEARS35-39,565132,0,0,0,0
240,Chagas disease,CHE,2010,BTSX,YEARS35-39,565132,0,0,0.83,0.15
250,Schistosomiasis,CHE,2010,BTSX,YEARS35-39,565132,0,0,0,0
260,Leishmaniasis,CHE,2010,BTSX,YEARS35-39,565132,0,0,0,0
270,Lymphatic filariasis,CHE,2010,BTSX,YEARS35-39,565132,0,0,0,0
280,Onchocerciasis,CHE,2010,BTSX,YEARS35-39,565132,0,0,0,0
285,Cysticercosis,CHE,2010,BTSX,YEARS35-39,565132,0,0,0,0
110,Diarrhoeal diseases,CHE,2010,BTSX,YEARS35-39,565132,0,0,163.32,28.9
130,Whooping cough,CHE,2010,BTSX,YEARS35-39,565132,0,0,0.07,0.01
140,Diphtheria,CHE,2010,BTSX,YEARS35-39,565132,0,0,0,0
150,Measles,CHE,2010,BTSX,YEARS35-39,565132,0,0,0,0
160,Tetanus,CHE,2010,BTSX,YEARS35-39,565132,0,0,0,0
170,Meningitis,CHE,2010,BTSX,YEARS35-39,565132,0,0,9.32,1.65
180,Encephalitis,CHE,2010,BTSX,YEARS35-39,565132,0,0,10.49,1.86
186,Acute hepatitis A,CHE,2010,BTSX,YEARS35-39,565132,0.02,0,13.74,2.43
340,Ascariasis,CHE,2010,BTSX,YEARS35-39,565132,0,0,0,0
350,Trichuriasis,CHE,2010,BTSX,YEARS35-39,565132,0,0,0,0
360,Hookworm disease,CHE,2010,BTSX,YEARS35-39,565132,0,0,0,0
362,Food-bourne trematodes,CHE,2010,BTSX,YEARS35-39,565132,0,0,0,0
365,Leprosy,CHE,2010,BTSX,YEARS35-39,565132,0,0,0,0
200,Acute hepatitis C,CHE,2010,BTSX,YEARS35-39,565132,0,0,0.24,0.04
400,Upper respiratory infections,CHE,2010,BTSX,YEARS35-39,565132,0,0,474.11,83.89
410,Otitis media,CHE,2010,BTSX,YEARS35-39,565132,0,0,75.12,13.29
300,Dengue,CHE,2010,BTSX,YEARS35-39,565132,0,0,0,0
310,Trachoma,CHE,2010,BTSX,YEARS35-39,565132,0,0,0,0
315,Yellow fever,CHE,2010,BTSX,YEARS35-39,565132,0,0,0,0
30,Tuberculosis,CHE,2010,BTSX,YEARS35-39,565132,0,0,22.26,3.94
50,Syphilis,CHE,2010,BTSX,YEARS35-39,565132,0,0,2.36,0.42
60,Chlamydia,CHE,2010,BTSX,YEARS35-39,565132,0,0,23.27,4.12
70,Gonorrhoea,CHE,2010,BTSX,YEARS35-39,565132,0,0,6.94,1.23
80,Trichomoniasis,CHE,2010,BTSX,YEARS35-39,565132,0,0,12.48,2.21
85,Genital herpes,CHE,2010,BTSX,YEARS35-39,565132,0,0,22.57,3.99
830,Depressive disorders,CHE,2010,BTSX,YEARS35-39,565132,0,0,5327.25,942.66
840,Bipolar disorder,CHE,2010,BTSX,YEARS35-39,565132,0,0,1552.83,274.77
811,Thalassaemias,CHE,2010,BTSX,YEARS35-39,565132,0.01,0,59.52,10.53
740,Prostate cancer,CHE,2010,BTSX,YEARS35-39,565132,0,0,3.05,0.54
753,Larynx cancer,CHE,2010,BTSX,YEARS35-39,565132,0,0,1.63,0.29
754,Thyroid cancer,CHE,2010,BTSX,YEARS35-39,565132,0,0,10.94,1.94
490,Neonatal conditions,CHE,2010,BTSX,YEARS35-39,565132,0,0,884.66,156.54
560,Iodine deficiency,CHE,2010,BTSX,YEARS35-39,565132,0,0,51.34,9.08
570,Vitamin A deficiency,CHE,2010,BTSX,YEARS35-39,565132,0,0,0,0
580,Iron-deficiency anaemia,CHE,2010,BTSX,YEARS35-39,565132,0,0,111.74,19.77
720,Corpus uteri cancer,CHE,2010,BTSX,YEARS35-39,565132,0,0,5.09,0.9
